Cambridge Investment Research Advisors, Inc. Sangamo Therapeutics, Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 25,790 shares of SGMO stock, worth $29,142. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,790
Previous 25,490
1.18%
Holding current value
$29,142
Previous $9,000
144.44%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding SGMO
# of Institutions
111Shares Held
56.8MCall Options Held
576KPut Options Held
1.17M-
Wasatch Advisors Inc Salt Lake City, UT19.4MShares$22 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.6MShares$10.8 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.85MShares$5.48 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$5.31 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.35MShares$2.66 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $177M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...